{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:34:21Z","timestamp":1778819661705,"version":"3.51.4"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1339,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pain Med"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1111\/j.1526-4637.2011.01260.x","type":"journal-article","created":{"date-parts":[[2011,10,25]],"date-time":"2011-10-25T15:33:02Z","timestamp":1319556782000},"page":"87-95","source":"Crossref","is-referenced-by-count":176,"title":["A History of Being Prescribed Controlled Substances and Risk of Drug Overdose Death"],"prefix":"10.1093","volume":"13","author":[{"given":"Leonard J.","family":"Paulozzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin M.","family":"Kilbourne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina G.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt B.","family":"Nolte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hema A.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Landen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry D.","family":"Loring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,1,1]]},"reference":[{"key":"2016030723063695000_13.1.87.1","unstructured":"Centers for Disease Control and Prevention. WONDER [Online]. Centers for Disease Control and Prevention (producer). 2011. Available at: http:\/\/wonder.cdc.gov (accessed April 2010)."},{"key":"2016030723063695000_13.1.87.2","doi-asserted-by":"crossref","unstructured":"Paulozzi LJ Logan JE Hall AJ A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. Addiction 2009;105:1541\u20138.","DOI":"10.1111\/j.1360-0443.2009.02650.x"},{"key":"2016030723063695000_13.1.87.3","doi-asserted-by":"crossref","unstructured":"Warner M Chen L Makuc D . Increase in fatal poisonings involving opioid analgesics in the United States, 1999\u20132006. 2009. Available at: http:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db22.htm (accessed June 2011).","DOI":"10.1037\/e665272010-001"},{"key":"2016030723063695000_13.1.87.4","doi-asserted-by":"crossref","unstructured":"Mueller MR Shah NG Landen MG . Unintentional prescription drug overdose deaths in New Mexico, 1994\u20132003. Am J Prev Med 2006;30:423\u20139.","DOI":"10.1016\/j.amepre.2005.12.011"},{"key":"2016030723063695000_13.1.87.5","unstructured":"Lanier WA . Prescription opioid overdose deaths\u2014Utah, 2008\u20132009. Epidemic Intelligence Service Conference. Atlanta, GA: Centers for Disease Control and Prevention, 2010."},{"key":"2016030723063695000_13.1.87.6","unstructured":"Coolen P Best S Lima A Sabel J Paulozzi L . Overdose deaths involving prescription opioids among Medicaid enrollees\u2014Washington, 2004\u20132007. MMWR Morb Mortal Wkly Rep 2009;58:1171\u20135."},{"key":"2016030723063695000_13.1.87.7","unstructured":"Wunsch MJ . Prescription overdose deaths in rural Virginia. 2007. Available at: http:\/\/www.dhp.virginia.gov\/dhp_programs\/pmp\/pmp_present.asp (accessed April 2010)."},{"key":"2016030723063695000_13.1.87.8","doi-asserted-by":"crossref","unstructured":"Shah N Lathrop S Reichard R Landen M . Unintentional drug overdose death trends in New Mexico (USA), 1990\u20132005: Combinations of heroin, cocaine, prescription opioids and alcohol. Addiction 2008;103:126\u201336.","DOI":"10.1111\/j.1360-0443.2007.02054.x"},{"key":"2016030723063695000_13.1.87.9","doi-asserted-by":"crossref","unstructured":"Cai R Crane E Poneleit K Paulozzi L . Emergency department visits involving nonmedical use of selected prescription drugs\u2014United States, 2004\u20132008. MMWR Morb Mortal Wkly Rep 2010;59:705\u20139.","DOI":"10.3109\/15360288.2010.503730"},{"key":"2016030723063695000_13.1.87.10","doi-asserted-by":"crossref","unstructured":"Hall AJ Logan JE Toblin RL Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008;300:2613\u201320.","DOI":"10.1001\/jama.2008.802"},{"key":"2016030723063695000_13.1.87.11","doi-asserted-by":"crossref","unstructured":"Paulozzi LJ Budnitz DS Xi Y . Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006;15:618\u201327.","DOI":"10.1002\/pds.1276"},{"key":"2016030723063695000_13.1.87.12","unstructured":"Weimer M Wunsch M . Source of methadone in 2004 medical examiner drug deaths. 2007. Available at: http:\/\/www.dhp.virginia.gov\/dhp_programs\/pmp\/pmp_present.asp (accessed June 2008)."},{"key":"2016030723063695000_13.1.87.13","doi-asserted-by":"crossref","unstructured":"Dunn KM Saunders KW Rutter CM Opioid prescriptions for chronic pain and overdose. Ann Intern Med 2010;152:85\u201392.","DOI":"10.7326\/0003-4819-152-2-201001190-00006"},{"key":"2016030723063695000_13.1.87.14","doi-asserted-by":"crossref","unstructured":"Braden JB Russo J Fan M-Y Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med 2010;170:1425\u201332.","DOI":"10.1001\/archinternmed.2010.273"},{"key":"2016030723063695000_13.1.87.15","doi-asserted-by":"crossref","unstructured":"Martyres R Cloade D Burns JM . Seeking drugs or seeking help? Escalating \u201cdoctor shopping\u201d by young heroin users before fatal overdose. Med J Aust 2004;180:211\u20134.","DOI":"10.5694\/j.1326-5377.2004.tb05887.x"},{"key":"2016030723063695000_13.1.87.16","doi-asserted-by":"crossref","unstructured":"VonKorff M Deyo RA . Potent opioids for chronic musculoskeletal pain: Flying blind? Pain 2004;109:207\u20130.","DOI":"10.1016\/j.pain.2004.02.019"},{"key":"2016030723063695000_13.1.87.17","doi-asserted-by":"crossref","unstructured":"Ballantyne JC Shin NS . Efficacy of opioids for chronic pain. Clin J Pain 2008;24:469\u201378.","DOI":"10.1097\/AJP.0b013e31816b2f26"},{"key":"2016030723063695000_13.1.87.18","doi-asserted-by":"crossref","unstructured":"Grady D Berkowitz S Katz MH . Opioids for chronic pain. Arch Intern Med 2011;171:1426\u20137.","DOI":"10.1001\/archinternmed.2011.213"},{"key":"2016030723063695000_13.1.87.19","unstructured":"U.S. Food and Drug Administration. National Drug Code Directory. Available at: http:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ucm142438.htm (accessed August 2010)."},{"key":"2016030723063695000_13.1.87.20","doi-asserted-by":"crossref","unstructured":"Campbell KM Deck D Krupski A . A comparison of Link Plus, The Link King, and a \u201cbasic\u201d deterministic algorithm. Health Informatics J 2008;14:5\u201315.","DOI":"10.1177\/1460458208088855"},{"key":"2016030723063695000_13.1.87.21","unstructured":"White AG Birnbaum HG Schiller M Tang J Katz NP . Analytic models to identify patients at risk for prescription opioid abuse. Am J Manag Care 2009;15:897\u2013906."},{"key":"2016030723063695000_13.1.87.22","doi-asserted-by":"crossref","unstructured":"Edlund MJ Steffick D Hudson T Harris KM Sullivan M . Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 2007;129:355\u201362.","DOI":"10.1016\/j.pain.2007.02.014"},{"key":"2016030723063695000_13.1.87.23","doi-asserted-by":"crossref","unstructured":"Wilsey BL Fishman SM Gilson AM Profiling multiple provider prescribing of opioids, benzodiazepines, stimulants, and anorectics. Drug Alcohol Depend 2010;112:99\u2013106.","DOI":"10.1016\/j.drugalcdep.2010.05.007"},{"key":"2016030723063695000_13.1.87.24","doi-asserted-by":"crossref","unstructured":"Katz N Panas L Kim M Usefulness of prescription monitoring programs for surveillance\u2014Analysis of Schedule II opioid prescription data in Massachusetts, 1996\u20132006. Pharmacoepidemiol Drug Saf 2010;19:115\u201323.","DOI":"10.1002\/pds.1878"},{"key":"2016030723063695000_13.1.87.25","unstructured":"Parente ST Kim SS Finch MD Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data. Am J Manag Care 2004;10:783\u201390."},{"key":"2016030723063695000_13.1.87.26","unstructured":"Goldberg GA . Identifying suboptimal management of persistent pain from integrated claims data: A feasibility study. Pharm Ther 2003;28:8\u201313."},{"key":"2016030723063695000_13.1.87.27","doi-asserted-by":"crossref","unstructured":"Gammaitoni AR Fine P Alvarez N McPherson M Bergmark S . Clinical application of opioid equianalgesic data. Clin J Pain 2003;19:286\u201397.","DOI":"10.1097\/00002508-200309000-00002"},{"key":"2016030723063695000_13.1.87.28","doi-asserted-by":"crossref","unstructured":"Kelly JP Cook SF Kaufman DW Prevalence and characteristics of opioid use in the US adult population. Pain 2008;138:507\u201313.","DOI":"10.1016\/j.pain.2008.01.027"},{"key":"2016030723063695000_13.1.87.29","doi-asserted-by":"crossref","unstructured":"Williams RE Sampson TJ Kalilani L Wurzelmann JI Janning SW . Epidemiology of opioid pharmacy claims in the United States. J Opioid Manag 2008;4:145\u201352.","DOI":"10.5055\/jom.2008.0019"},{"key":"2016030723063695000_13.1.87.30","doi-asserted-by":"crossref","unstructured":"Roe CM McNamara AM Motheral BR . Gender- and age-related prescription drug use patterns. Ann Pharmacother 2002;36:30\u20139.","DOI":"10.1345\/aph.1A113"},{"key":"2016030723063695000_13.1.87.31","unstructured":"Colliver JD Kroutil LA Dai L Gfroerer JC . Rockville, MD: Substance Abuse and Mental Health Services Administration. 2006."},{"key":"2016030723063695000_13.1.87.32","doi-asserted-by":"crossref","unstructured":"Inciardi JA Surratt HL Kurtz SP Cicero TJ . Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med 2007;8:171\u201383.","DOI":"10.1111\/j.1526-4637.2006.00255.x"},{"key":"2016030723063695000_13.1.87.33","unstructured":"Coolen P . Patient Review and Coordination Program. 2009. Available at: http:\/\/www.safestates.org\/displaycommon.cfm?an=1&subarticlenbr=204 (accessed March 2010)."},{"key":"2016030723063695000_13.1.87.34","doi-asserted-by":"crossref","unstructured":"Hays L Kirsh KL Passik SD . Seeking drug treatment for OxyContin abuse: A chart review of consecutive admissions to a substance abuse treatment facility in Kentucky. J Natl Compr Canc Netw 2003;1:423\u20138.","DOI":"10.6004\/jnccn.2003.0035"},{"key":"2016030723063695000_13.1.87.35","doi-asserted-by":"crossref","unstructured":"Bohnert AS Valenstein M Bair MJ Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011;305:1315\u201321.","DOI":"10.1001\/jama.2011.370"},{"key":"2016030723063695000_13.1.87.36","doi-asserted-by":"crossref","unstructured":"Gomes T Juurlink DN Dhalla IA Trends in opioid use and dosing among socio-economically disadvantaged patients. Open Med 2011;5:E13\u201322.","DOI":"10.12927\/hcq.2011.22153"},{"key":"2016030723063695000_13.1.87.37","doi-asserted-by":"crossref","unstructured":"Portenoy RK Foley KM . Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases. Pain 1986;25:171\u201386.","DOI":"10.1016\/0304-3959(86)90091-6"},{"key":"2016030723063695000_13.1.87.38","unstructured":"Washington State Agency Medical Directors' Group. Interagency guideline on opioid dosing for chronic non-cancer pain. Available at: http:\/\/www.agencymeddirectors.wa.gov (accessed March 2008)."},{"key":"2016030723063695000_13.1.87.39","unstructured":"Sundwall DN Rolfs RT Johnson E . Utah clinical guidelines on prescribing opioids for treatment of pain. 2009. Available at: http:\/\/health.utah.gov\/prescription\/index.html (accessed February 2010)."},{"key":"2016030723063695000_13.1.87.40","doi-asserted-by":"crossref","unstructured":"Walsh SL Preston KL Stitzer ML Cone EJ Bigelow GE . Clinical pharmacology of buprenorphine: Ceiling effects at high doses. Clin Pharmacol Ther 1994;55:569\u201380.","DOI":"10.1038\/clpt.1994.71"},{"key":"2016030723063695000_13.1.87.41","doi-asserted-by":"crossref","unstructured":"Ravndal E Amundsen EJ . Mortality among drug users after discharge from inpatient treatment: An 8-year prospective study. Drug Alcohol Depend 2009;108:65\u20139.","DOI":"10.1016\/j.drugalcdep.2009.11.008"},{"key":"2016030723063695000_13.1.87.42","doi-asserted-by":"crossref","unstructured":"Webster LR Cochella S Dasgupta N An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med 2011;12:S26\u201335.","DOI":"10.1111\/j.1526-4637.2011.01134.x"},{"key":"2016030723063695000_13.1.87.43","doi-asserted-by":"crossref","unstructured":"Dasgupta N Kramer E Zalman M Association between non-medical and prescriptive use of opioids. Drug Alcohol Depend 2006;82:135\u201342.","DOI":"10.1016\/j.drugalcdep.2005.08.019"},{"key":"2016030723063695000_13.1.87.44","doi-asserted-by":"crossref","unstructured":"Butler SF Fernandez KC Chang A Measuring attractiveness for abuse of prescription opioids. Pain Med 2010;11:67\u201380.","DOI":"10.1111\/j.1526-4637.2009.00736.x"},{"key":"2016030723063695000_13.1.87.45","unstructured":"Dormitzer C . Summary of drug abuse \u201crates\u201d in the United States. 2008. Available at: http:\/\/www.fda.gov\/ohrms\/dockets\/AC\/08\/slides\/2008-4356s1-04-FDA-corepresentations.ppt#307,13,Summary (accessed January 2010)."},{"key":"2016030723063695000_13.1.87.46","doi-asserted-by":"crossref","unstructured":"Katz N Houle B Fernandez KC Update on prescription monitoring in clinical practice: A survey study of prescription monitoring program administrators. Pain Med 2008;9:587\u201394.","DOI":"10.1111\/j.1526-4637.2008.00471.x"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/13\/1\/87\/5246811\/13-1-87.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,12]],"date-time":"2021-12-12T15:41:15Z","timestamp":1639323675000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-lookup\/doi\/10.1111\/j.1526-4637.2011.01260.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,1]]},"published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.1111\/j.1526-4637.2011.01260.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1526-4637.2011.01260.x","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}